Inactive Instrument
Abliva AB Stock
Stocks
ABLI
SE0002575340
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +0.23% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 59 | 10/01/2014 | |
Dag Nesse
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/02/2023 |
Magnus Hansson
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/01/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 72 | 06/11/2017 | |
| Director/Board Member | 66 | 27/04/2017 | |
David Bejker
BRD | Director/Board Member | 51 | 27/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07/03/25 | Sell | Founder | 574,978 | 0.0357% | ||
| 07/03/25 | Sell | Founder | 574,978 | 0.0357% | ||
| 12/02/25 | Sell | Chief Technology Officer | 3,104,000 | 0.1926% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.23% | -1.11% | - | - | 76M | |
| -3.74% | -1.56% | +45.14% | +64.45% | 55.2B | |
| -0.81% | -0.33% | +27.15% | +81.12% | 55.6B | |
| -0.11% | +0.86% | -15.63% | -14.71% | 23.51B | |
| -1.58% | -5.51% | -3.51% | +359.44% | 22.35B | |
| -4.01% | -2.68% | +12.50% | -12.70% | 20.6B | |
| -1.23% | -3.51% | +25.70% | -31.88% | 17.45B | |
| -3.34% | -6.96% | +22.02% | +515.48% | 15.16B | |
| +1.16% | +0.58% | +51.87% | +183.97% | 13.91B | |
| -5.09% | -13.14% | +151.85% | +272.20% | 13.74B | |
| Average | -1.85% | -1.55% | +35.23% | +157.49% | 26.39B | |
| Weighted average by Cap. | -2.10% | -0.46% | +31.17% | +122.32% |
Employees
6
